BW
Bruce Walcheck
Principal Investigator
University of Minnesota
I'm working on
7 months ago
Immunology, Cell Biology, NK Cell Therapy, Therapeutic Antibodies
About
Bruce Walcheck advances cancer immunotherapy through translational NK cell research. Inventor on a non‑provisional patent for targeted ADAM17 blockers, combining cytokine modulation with protease checkpoint control to improve NK activation, expansion, and persistence for adoptive therapy.
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.